Natco Pharma Q2 Results
- BSE: 524816
- NSE: NATCOPHARM
- ISIN: INE987B01026
- Sector: Biotechnology & Drugs
BSE
1,369.2
13.20 (0.97%)
13.20 (0.97%)Volume17.41 K
Updated: Mon 25 Nov, 2024 | 15:29:00
NSE
1,364.957.35 (0.54%)
7.35 (0.54%)Volume5.72 L
Updated: Mon 25 Nov, 2024 | 15:43:45
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹1,371.10 Cr.(0.62%)
- Operating Profit₹758.50 Cr.(-0.29%)
- Profit After Tax₹677.30 Cr.(1.32%)
- Operating Margin55.32%(37.69%)
Note: Comparison is on YoY basis
Quarterly - Natco Pharma Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 1,371.10 | 1,140.50 | -% | 1,031.40 | -% |
| Selling/ General/ Admin Expenses Total | 151.50 | 138.20 | -% | 122.40 | -% |
| Depreciation/ Amortization | 45.80 | 43.50 | -% | 43.60 | -% |
| Other Operating Expenses Total | 237.70 | 278.30 | -% | 235.20 | -% |
| Total Operating Expense | 612.60 | 656.00 | -% | 617.00 | -% |
| Operating Income | 758.50 | 484.50 | -% | 414.40 | -% |
| Net Income Before Taxes | 818.20 | 500.00 | -% | 439.60 | -% |
| Net Income | 677.30 | 420.30 | -% | 369.00 | -% |
| Diluted Normalized EPS | 37.81 | 23.26 | -% | 20.60 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST